From: Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
Time | Control | 48Â h | 72Â h |
---|---|---|---|
Treatment | % Cell migration capacity | ||
Untreated | 94 | 95.33 | 96.98 |
AZ | 93.66 | 90.3 | 85.87 |
- | - | p < 0.01 | |
MS-275 | 94 | 42.33 | 38.56 |
p < 0.001 | p < 0.001 | ||
AZ + MS-275 | 95 | 37 | 26 |
p < 0.001 | p < 0.001 |